Mistletoe therapy
Botany
Mistletoe is the general term given to the parasitic and hemi-parasitic tree dwelling genuses of the family Viscaceae which contains three genera of mistletoe:
- Arceuthobium (dwarf mistletoe)
- Phoradendron (American mistletoe)
- Viscum (mistletoe)[1]
- ↑ <ref>Agrios, G. N. (2005). "Plant Pathology". PLANT DISEASES CAUSED BY PARASITIC HIGHER PLANTS, INVASIVE CLIMBING PLANTS, AND PARASITIC GREEN ALGAE. Elsevier. pp. 705–722. doi:10.1016/B978-0-08-047378-9.50019-1. ISBN 9780120445653.
American Mistletoe (Phoradendron serotinum) has a history of use in Mexican and South American traditional medicine for the treatment of cancer.[1]
- ↑ <ref>Alonso-Castro, A. J., Juárez-Vázquez, M. del C., Domínguez, F., González-Sánchez, I., Estrada-Castillón, E., López-Toledo, G., Chávez, M., Cerbón, M. A., García-Carranca, A. (1 August 2012). "The antitumoral effect of the American mistletoe Phoradendron serotinum (Raf.) M.C. Johnst. (Viscaceae) is associated with the release of immunity-related cytokines". Journal of Ethnopharmacology. 142 (3): 857–864. doi:10.1016/j.jep.2012.06.018. Retrieved 13 March 2023.
European Mistletoe (Viscum Album) is the genus with the most scientific interest. It was used in traditional European herbal medicine for non-oncologic conditions including epilepsy, hypertension, and heart failure. In 1917
Mistletoe therapy is the therapeutic use of mistletoe (mainly viscum album). A main field of use in anthroposophic medicine is the treatment of cancer, there is also nononcological uses for example in rheumatic disorders.
Literature
- Johnson, Steven; Winters, Nasha; Blanning, Adam; Debus, Marion; Faust, Paul; Hancock, Mark; Hinderberger, Peter (2022-02-25). Mistletoe and the Emerging Future of Integrative Oncology. SteinerBooks, Incorporated. ISBN 978-1-938685-33-0.
Weblinks
- https://www.mistletoe-therapy.org/
- Anthromedics: Principles and Application of Mistletoe Therapy in Oncology: https://www.anthromedics.org/PRA-0897-EN